EVI2B

EVI2B
Identifiers
Aliases	EVI2B, CD361, D17S376, EVDB, ecotropic viral integration site 2B
External IDs	OMIM: 158381; MGI: 5439444; HomoloGene: 48438; GeneCards: EVI2B; OMA:EVI2B - orthologs
Gene location (Human) Chr. Chromosome 17 (human) Band 17q11.2 Start 31,303,770 bp End 31,314,105 bp
Gene location (Mouse) Chr. Chromosome 11 (mouse) Band 11 B5|11 Start 79,404,211 bp End 79,421,415 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in monocyte blood granulocyte bone marrow bone marrow cell trabecular bone spleen appendix lymph node right lung Top expressed in granulocyte bone marrow blood thymus tail of embryo spleen genital tubercle aortic valve lip esophagus More reference expression data BioGPS More reference expression data
Orthologs Species Human Mouse Entrez 2124 101488212 Ensembl ENSG00000185862 ENSMUSG00000070354 UniProt P34910 Q8VD58 RefSeq (mRNA) NM_006495 NM_146023 RefSeq (protein) NP_006486 NP_666135 NP_001070964 Location (UCSC) Chr 17: 31.3 – 31.31 Mb Chr 11: 79.4 – 79.42 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Protein EVI2B is a protein that in humans is encoded by the EVI2B gene.

Further reading

• Xu G, O'Connell P, Stevens J, White R (1992). "Characterization of human adenylate kinase 3 (AK3) cDNA and mapping of the AK3 pseudogene to an intron of the NF1 gene". Genomics. 13 (3): 537–42. doi:10.1016/0888-7543(92)90122-9. PMID 1639383.
• Wallace MR, Andersen LB, Saulino AM, et al. (1991). "A de novo Alu insertion results in neurofibromatosis type 1" (PDF). Nature. 353 (6347): 864–6. Bibcode:1991Natur.353..864W. doi:10.1038/353864a0. hdl:2027.42/62641. PMID 1719426. S2CID 4309841.
• Viskochil D, Cawthon R, O'Connell P, et al. (1991). "The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene". Mol. Cell. Biol. 11 (2): 906–12. doi:10.1128/mcb.11.2.906. PMC 359746. PMID 1899288.
• Cawthon RM, Weiss R, Xu GF, et al. (1990). "A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations". Cell. 62 (1): 193–201. doi:10.1016/0092-8674(90)90253-B. PMID 2114220. S2CID 8201518.
• Cawthon RM, O'Connell P, Buchberg AM, et al. (1990). "Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts". Genomics. 7 (4): 555–65. doi:10.1016/0888-7543(90)90199-5. PMID 2117566.
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
• Douglas J, Cilliers D, Coleman K, et al. (2007). "Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth". Nat. Genet. 39 (8): 963–5. doi:10.1038/ng2083. hdl:2381/22044. PMID 17632510. S2CID 35797973.